Gut–Brain Axis in Depression: A Narrative Review of Microbiome Signatures, Mechanisms, Biomarkers, and Microbiota-Targeted Interventions
DOI:
https://doi.org/10.12775/QS.2026.53.70176Keywords
Gut-brain axis, Gut microbiota, Depression, Inflammation, Probiotics, BiomarkersAbstract
Background. The microbiota–gut–brain axis (MGBA) is a key pathway in the pathophysiology of depression, integrating neural, immune, and metabolic mechanisms and influencing processes relevant to mood regulation.
Aim. This narrative review summarizes current evidence on the role of the MGBA in depression, including microbial composition, functional pathways, biomarkers, and therapeutic interventions.
Material and methods. A literature search was conducted in PubMed and PMC (2018–March 2026, including key earlier studies). The review focused on microbial alterations, metagenomic functions, intestinal barrier and immune biomarkers, microbial metabolites, and clinical trials.
Results. Cohort studies show associations between depressive symptoms and gut microbial taxa involved in neuroactive pathways; however, findings are heterogeneous and of limited diagnostic value. Experimental studies support causality, as microbiota from patients with major depressive disorder induce depression-like behaviors in rodents. Vagal nerve integrity appears necessary for some microbiota-mediated effects, and stress-related dysbiosis may contribute to microglial activation and impaired neurogenesis. Biomarker studies indicate increased intestinal permeability and elevated markers of microbial translocation (e.g., zonulin, LPS-binding protein, sCD14), though their clinical utility remains unclear. Clinical trials suggest probiotics may reduce depressive symptoms as adjunctive therapy, while evidence for prebiotics is inconsistent and fecal microbiota transplantation remains experimental.
Conclusions. The MGBA plays an important role in depression, but further standardized and longitudinal studies are needed to clarify mechanisms and support clinical applications, particularly for personalized therapies.
References
[1] Radjabzadeh D, Bosch JA, Uitterlinden AG, et al. Gut microbiome-wide association study of depressive symptoms. Nat Commun. 2022;13(1):7128. https://doi.org/10.1038/s41467-022-34502-3
[2] Cryan JF, O'Riordan KJ, Cowan CSM, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877-2013. https://doi.org/10.1152/physrev.00018.2018
[3] Liang S, Wu X, Jin F. Gut-brain psychology: rethinking psychology from the microbiota-gut-brain axis. Front Integr Neurosci. 2018;12:33. https://doi.org/10.3389/fnint.2018.00033
[4] Ng QX, Peters C, Ho CYX, et al. A meta-analysis of the use of probiotics to alleviate depressive symptoms. J Affect Disord. 2018;228:13-19. https://doi.org/10.1016/j.jad.2017.11.063
[5] Valles-Colomer M, Falony G, Darzi Y, et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol. 2019;4(4):623-632. https://doi.org/10.1038/s41564-018-0337-x
[6] Yang J, Zheng P, Li Y, et al. Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders. Sci Adv. 2020;6(49):eaba8555. https://doi.org/10.1126/sciadv.aba8555
[7] Morena D, Lippi M, Scopetti M, et al. Leaky gut biomarkers as predictors of depression and suicidal risk: a systematic review and meta-analysis. Diagnostics (Basel). 2025;15(13):1683. https://doi.org/10.3390/diagnostics15131683
[8] Bibolar AC, Crecan-Suciu BD, Păunescu RL, et al. Intestinal permeability and depression: a narrative review of selected blood-based biomarkers. Int J Mol Sci. 2025;26(20):10076. https://doi.org/10.3390/ijms262010076
[9] Agirman G, Yu KB, Hsiao EY. Signaling inflammation across the gut-brain axis. Science. 2021;374(6571):1087-1092. https://doi.org/10.1126/science.abi6087
[10] Ting EY, Yang AC, Tsai SJ. Role of interleukin-6 in depressive disorder. Int J Mol Sci. 2020;21(6):2194. https://doi.org/10.3390/ijms21062194
[11] Milaneschi Y, Simmons WK, van Rossum EFC, et al. Depression and obesity: evidence of shared biological mechanisms. Mol Psychiatry. 2019;24(1):18-33. https://doi.org/10.1038/s41380-018-0017-5
[12] Kreuzer K, Birkl-Toeglhofer AM, Haybaeck J, et al. PROVIT-CLOCK: a potential influence of probiotics and vitamin B7 add-on treatment and metabolites on clock gene expression in major depression. Neuropsychobiology. 2024;83(3-4):135-151. https://doi.org/10.1159/000538781
[13] Gao K, Pi Y, Mu CL, et al. Increasing carbohydrate availability in the hindgut promotes hypothalamic neurotransmitter synthesis: aromatic amino acids linking the microbiota-brain axis. J Neurochem. 2019;149(5):641-659. https://doi.org/10.1111/jnc.14709
[14] Lukić I, Ivković S, Mitić M, et al. Tryptophan metabolites in depression: modulation by gut microbiota. Front Behav Neurosci. 2022;16:987697. https://doi.org/10.3389/fnbeh.2022.987697
[15] Lukić I, Getselter D, Ziv O, et al. Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior. Transl Psychiatry. 2019;9(1):133. https://doi.org/10.1038/s41398-019-0466-x
[16] Kazemi A, Noorbala AA, Azam K, et al. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial. Clin Nutr. 2019;38(2):522-528. https://doi.org/10.1016/j.clnu.2018.04.010
[17] Siopi E, Galerne M, Rivagorda M, et al. Gut microbiota changes require vagus nerve integrity to promote depressive-like behaviors in mice. Mol Psychiatry. 2023;28(7):3002-3012. https://doi.org/10.1038/s41380-023-02071-6
[18] Zhu S, Jiang Y, Xu K, et al. The progress of gut microbiome research related to brain disorders. J Neuroinflamm. 2020;17(1):25. https://doi.org/10.1186/s12974-020-1705-z
[19] Heidarzadeh-Rad N, Gökmen-Özel H, Kazemi A, et al. Effects of a psychobiotic supplement on serum brain-derived neurotrophic factor levels in depressive patients: a post hoc analysis of a randomized clinical trial. J Neurogastroenterol Motil. 2020;26(4):486-495. https://doi.org/10.5056/jnm20079
[20] He H, He H, Mo L, et al. Priming of microglia with dysfunctional gut microbiota impairs hippocampal neurogenesis and fosters stress vulnerability of mice. Brain Behav Immun. 2024;115:280-294. https://doi.org/10.1016/j.bbi.2023.10.031
[21] Nikolova VL, Smith MRB, Hall LJ, et al. Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis. JAMA Psychiatry. 2021;78(12):1343-1354. https://doi.org/10.1001/jamapsychiatry.2021.2573
[22] Zhang Q, Chen B, Zhang J, et al. Effect of prebiotics, probiotics, synbiotics on depression: results from a meta-analysis. BMC Psychiatry. 2023;23(1):477. https://doi.org/10.1186/s12888-023-04963-x
[23] Schaub AC, Schneider E, Vazquez-Castellanos JF, et al. Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial. Transl Psychiatry. 2022;12(1):227. https://doi.org/10.1038/s41398-022-01977-z
[24] Green JE, Berk M, Mohebbi M, et al. Feasibility, acceptability, and safety of faecal microbiota transplantation in the treatment of major depressive disorder: a pilot randomized controlled trial. Can J Psychiatry. 2023;68(5):315-326. https://doi.org/10.1177/07067437221150508
[25] Zheng P, Zeng B, Zhou C, et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol Psychiatry. 2016;21(6):786-796. https://doi.org/10.1038/mp.2016.44
[26] Kelly JR, Borre Y, O'Brien C, et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res. 2016;82:109-118. https://doi.org/10.1016/j.jpsychires.2016.07.019
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Izabela Ślinko, Zuzanna Panas, Ewa Dryl-Jarmoc, Gabriela Kuliś, Mateusz Zimowski, Jakub Dziemiańczuk, Mateusz Czajkowski, Kacper Krawczuk, Piotr Kadysz, Agata Kolanek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 82
Number of citations: 0
